7 completed. 7 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 7 | Completed 7 |
Follow Respimat: new trials by email Literature Review of Respimat trials Research Report on Respimat
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect on Exercise Endurance and Lung Hyperinflation of Tiotropium + Olodaterol in COPD Patients Placebo, Tiotropium, Olodaterol - Pulmonary Disease, Chronic Obstructive | Phase 3 | Completed | Boehringer Ingelheim | 295 | 2012-03-01 | 2015-09-15 |
| Characterization of 24-hour Lung Function Profiles of Inhaled Tiotropium + Olodaterol Fixed Dose Combination in Patients Suffering From Chronic Obstructive Pulmonary Disease tiotropium + olodaterol, tiotropium, olodaterol - Pulmonary Disease, Chronic Obstructive | Phase 3 | Completed | Boehringer Ingelheim | 219 | 2012-03-01 | 2015-07-16 |
| Effect on Exercise Endurance and Lung Hyperinflation of Tiotropium + Olodaterol in COPD Patients. Placebo, Tiotropium + Olodaterol, tiotropium + Olodaterol - Pulmonary Disease, Chronic Obstructive | Phase 3 | Completed | Boehringer Ingelheim | 291 | 2012-02-01 | 2015-09-15 |
| Japan Long-term Safety for Tiotropium Plus Olodaterol Tiotropium + Olodaterol, Respimat, Olodaterol - Pulmonary Disease, Chronic Obstructive | Phase 3 | Completed | Boehringer Ingelheim | 122 | 2012-02-01 | 2015-07-15 |
| Tiotropium+Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD) tiotropium + olodaterol, tiotropium, olodaterol - Pulmonary Disease, Chronic Obstructive | Phase 3 | Completed | Boehringer Ingelheim | 2624 | 2011-09-01 | 2015-07-16 |
| Tiotropium +Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD) tiotropium + olodaterol, tiotropium, olodaterol - Pulmonary Disease, Chronic Obstructive | Phase 3 | Completed | Boehringer Ingelheim | 2539 | 2011-09-01 | 2015-07-16 |
| Tiotropium / Respimat One Year Study in COPD. Respimat, Tiotropium - Pulmonary Disease, Chronic Obstructive | Phase 3 | Completed | Boehringer Ingelheim | 3991 | 2006-09-01 | 2014-05-16 |
Pulmonary Disease, Chronic Obstructive (7)
Canada (6) · Germany (6) · United States (6) · Hungary (4) · Netherlands (4) · Argentina (3) · Australia (3) · Austria (3) · Belgium (3) · China (3) · Denmark (3) · India (3) · Italy (3) · Japan (3) · Russia (3)
PMID 32943047, PMID 25573406, PMID 26112656, PMID 27993292, PMID 28424359, PMID 29355547, PMID 30261995, PMID 32462607, PMID 32671684, PMID 32776202, PMID 32848379, PMID 32848380, PMID 33175291, PMID 20620037, PMID 25956072
2009 (2)